Inactive Instrument
Neutra Corp Stock Other OTC
Stocks
US64129C2044
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 25-03-31 | Neutra Corp. executed a letter of intent to acquire CuraConnector.com, Inc. | CI |
| 24-08-07 | Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2024 | CI |
| Market Cap | 460K 403K 373K 343K 647K 44.37M 657K 4.46M 1.75M 21.71M 1.73M 1.69M 74.8M | P/E 2023 |
-1.94x | P/E 2024 | -3.75x |
|---|---|---|---|---|---|
| Enterprise Value | 525K 460K 425K 391K 738K 50.59M 749K 5.08M 1.99M 24.75M 1.97M 1.93M 85.29M | EV / Sales 2023 |
18,402,377x | EV / Sales 2024 | 23,773,714x |
| Free-Float |
99.31% | Yield 2023 * |
-
| Yield 2024 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Sydney Jim
CEO | Chief Executive Officer | 41 | 2013-05-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sydney Jim
CHM | Chairman | 41 | 2014-08-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.90% | -1.23% | +53.16% | +151.68% | 1,051B | |
| -0.62% | -2.49% | +52.93% | +49.28% | 609B | |
| -0.41% | +2.48% | +37.49% | +78.74% | 450B | |
| -0.75% | +0.30% | +29.77% | +21.15% | 330B | |
| -1.52% | -1.19% | +34.46% | +35.35% | 284B | |
| -1.70% | -1.82% | +20.99% | +15.74% | 263B | |
| -0.58% | +1.11% | -20.18% | -40.59% | 223B | |
| +0.03% | +1.78% | +23.99% | +57.29% | 198B | |
| -0.50% | +1.70% | +23.41% | +67.16% | 167B | |
| Average | -0.78% | +0.54% | +28.45% | +48.42% | 397.23B | |
| Weighted average by Cap. | -0.85% | +0.02% | +37.56% | +72.59% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 0.07 0.06 0.06 0.05 0.1 6.56 0.1 0.66 0.26 3.21 0.26 0.25 11.05 | 0.04 0.03 0.03 0.03 0.06 3.81 0.06 0.38 0.15 1.87 0.15 0.15 6.43 |
| Net income | -561K -492K -455K -418K -789K -54.14M -802K -5.44M -2.13M -26.49M -2.11M -2.06M -91.26M | -233K -205K -189K -174K -328K -22.51M -334K -2.26M -887K -11.02M -877K -858K -37.95M |
| Net Debt | 54.5K 47.77K 44.16K 40.61K 76.63K 5.26M 77.85K 528K 207K 2.57M 205K 200K 8.86M | 64.5K 56.54K 52.26K 48.06K 90.68K 6.22M 92.14K 625K 245K 3.04M 242K 237K 10.49M |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
